12:00 AM
Aug 27, 2012
 |  BC Week In Review  |  Company News  |  Deals

BioSyent deal

BioSyent's BioSyent Pharma Inc. subsidiary received exclusive Canadian rights to two undisclosed products from an undisclosed...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >